Overview

Study of Sargramostim in Patients With COVID-19

Status:
Completed

Trial end date:
2021-05-19

Target enrollment:

Participant gender:

Summary

The purpose of this research is to find out if a drug (sargramostim) also known as Leukine® could help patient recover faster from COVID-19. Sargramostim may help the lungs recover from the effects of COVID-19, and this research study will help to find this out.

Phase:

Phase 2

Details

Lead Sponsor:

Partner Therapeutics, Inc.

Collaborator:

United States Department of Defense

Treatments:

Sargramostim